AzTrials
AzTrials

Substance UseHOMENCT04135703

Prevention of OUD: The HOME Project (Housing, Opportunities, Motivation and Engagement)

A study testing Risk Prevention Services + Housing and Risk Prevention Services Only in people with Substance Use, run by Ohio State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Homeless youth have a much higher rate of substance use than non-homeless peers with evidence suggesting that homeless youth have the highest rates of opioid use among youth subgroups in the country (Brands et al., 2005); heroin using homeless youth also appear to have the highest rates of IV drug use and HIV (Rhoades… Read more about this study

Who is it for?
Ages 18 to 24 yearsHealthy volunteers can take part
Conditions the study is for
Substance Use
What is being tested?
Risk Prevention Services + Housing and Risk Prevention Services Only
Could I receive a placebo?
No, everyone receives an active treatment
How many people
240 participants
Where
1 siteUnited States
Study dates
23 Jun 2020to 14 May 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • ages of 18 to 24 years
  • meets McKinney-Vento definition of homeless
  • fails to meet DSM 5 criteria for Opioid Use Disorder as assessed by the SCID

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Ohio State University

    Columbus, Ohio, 43210

Other trials in United States

About this study

Official title: Prevention of OUD: The HOME (Housing, Opportunities, Motivation and Engagement) Randomized Trial

Homeless youth have a much higher rate of substance use than non-homeless peers with evidence suggesting that homeless youth have the highest rates of opioid use among youth subgroups in the country (Brands et al., 2005); heroin using homeless youth also appear to have the highest rates of IV drug use and HIV (Rhoades et al., 2014). Given the high rates of opioid use, exposure to violence, mental and physical health challenges, and high rates of mortality in homeless youth, it is surprising that no study to date utilizes a randomized controlled design to test prevention of opioid and other drug use among this vulnerable population. Resolution of youth homelessness through housing and prevention services, often referred to as "Housing First", as proposed in the current study, has great potential to reduce the likelihood for the development of an opioid use disorder as well as other problem behaviors associated with living on the streets. However, only 20-30% of homeless youth samples report ever having stayed at a crisis shelter, 9% report having ever accessed mental health services, and 15% report ever having received substance use treatment (Ray, 2006) indicating a need to reach and engage youth in services that are feasible and acceptable. This study will provide essential information for researchers and providers on the efficacy of housing + opioid and related risk prevention services in an RCT on opioid use, how moderators affect the response, and mechanisms underlying change.

Read the detailed description

The overarching goal of this application is to evaluate a comprehensive intervention for the prevention of opioid use disorder and for increasing other resilient outcomes in this special population of high-risk young adults. Phase I of the study includes a nonrandomized pilot study with a sample of 21 youth to assess initial efficacy, feasibility of recruitment and acceptability of the housing + opioid and related risk prevention services. Upon meeting transition milestones, 240 youth will be randomized into housing + opioid and related risk prevention services versus opioid and related risk prevention services alone for Phase II. In this study, we seek to determine if adding housing to opioid and related risk prevention services yields a significant benefit above and beyond the benefit yielded by opioid and related risk prevention services alone. Phase II follow-up will be conducted at 3, 6, 9 and 12-months post-baseline to assess stability of effects. Sample inclusion criteria, recruitment and screening will be identical for both phases, as described below. The unique components of Phase I and Phase II are then described separately.

Sample Inclusion Criteria.

  1. We will include youth between the ages of 18 to 24 years.
  2. Youth meets the criteria for homelessness as defined by the federal McKinney-Vento Act (2002) as "lacking a fixed, regular, stable, and adequate nighttime residence" and includes "living in a publicly or privately operated shelter designed to provide temporary living accommodations, or a public or private place not designed for, or ordinarily used as, regular sleeping accommodations for human beings."
  3. Youth fails to meet DSM 5 criteria for Opioid Use Disorder as assessed by the SCID (First et al., 2015).
  4. Those who report suicide ideation on the Scale for Suicide Ideation - Worst Point (SSI-W) (Beck, Brown, \& Steer, 1997) will also receive suicide prevention.

Participant recruitment and sample availability. Service-connected youth will be recruited from the drop-in and adult shelters, non-service connected youth will be recruited through outreach to local soup kitchens, sandwich lines, the streets, parks and library. Given the high rates of homeless youth in Columbus, we do not anticipate any recruitment problems.

Screening and intake. Project staff will maintain offices within the drop-in center. Youth who are engaged on the streets will be transported to the drop-in center. An RA will engage and screen youth to determine basic eligibility for the study. After the brief screening and stated interest in the project, written consent will be obtained and the Structured Clinical Interview for DSM-5 Disorders (SCID) (First, Williams, Karg, \& Spitzer, 2015) section on Opioid Use Disorder, will be administered to determine formal eligibility.

The Community Advisory Group, including homeless providers, homeless youth, landlords, substance use treatment experts and policy makers will meet throughout the project period, shaping study procedures, and easing transition of intervention to practice by the end of the study.

Phase I (UG3) Using the same recruitment strategy, eligibility criteria and assessment package (including stress biomarkers) as Phase II, a non-randomized pilot of the housing + opioid and related risk prevention services intervention (N = 21) will be completed in year 1. The sample size of 21 reflects three months of recruitment of seven youth/month. All youth will receive the 6-month housing + opioid and related prevention services intervention. Youth will be assessed at baseline, 3 and 6-months using the proposed assessment battery, and qualitative interviews. The primary purpose of this phase is to document feasibility of recruitment, acceptability of the intervention, and initial pre-post change on targeted outcome measures. As the housing + prevention services and assessment battery are identical in Phase 1 and Phase II, they are described in detail following the description of Phase II. Those aspects unique to Phase I are discussed immediately below.

Phase I: Assessment of acceptability, feasibility and initial efficacy of the intervention. Acceptability of the intervention will be assessed by the retention of youths in the intervention, the total number of advocacy sessions attended, length of time remaining in project supported housing, and by the percentage of eligible youth who agree to participate in the study. In addition, the extent to which landlords consent to continuing participation in the second phase of the trial is essential. Assessment of feasibility includes documentation of 1) whether participants can be recruited, engaged, and maintained in the housing + opioid and related risk prevention services as proposed, data which can be obtained from RA screening forms and advocate records (meetings attended, maintenance of housing), and 2) whether the timeline proposed for housing youths (anticipated to average 4 weeks, and time to housing will be tracked) and other intervention procedures can be maintained as proposed. In order to estimate initial efficacy, we will assess youth at baseline, 3 and 6-months to determine change in identified targeted outcomes (e.g. opioid and other substance use, homelessness and related problems). In addition to the quantitative analysis, qualitative interviews with each youth will provide a fuller understanding of the youths' response to the intervention.

Phase I: Quantitative Analysis. Repeated measures ANOVA will be used to test the efficacy of the intervention (time effects). Three testing occasions (e.g., baseline, 3, and 6 months) will be the within-subject dependent variables. The primary outcome is opioid use, and secondary outcomes are listed below under "dependent variables." It is predicted that there will be a main effect of time; youth will show reductions in opioid use, and improved functioning in other domains at post-intervention (6-months).

Phase I: Qualitative Analysis. In order to increase our understanding of youths' response to the intervention such as experiences associated with differing levels of housing success and satisfaction with services, each youth at 6 months post-baseline will be interviewed regarding their experiences in the study. Supplementing the quantitative findings, interviews can provide better understanding of factors that promote engagement and success among youth as well as factors that prevented youth from successfully maintaining their housing. Additionally, qualitative data can help explain any unexpected findings, and provide a greater richness when reporting and interpreting the quantitative outcomes.

Phase II (UH3) In Phase II, 240 homeless youths between the ages of 18 to 24 years recruited from the streets and drop-in center will be randomly assigned to 1) 6-months of housing + opioid and related risk prevention services (n = 120), or to 2) opioid and related risk prevention services alone (n = 120). In addition, all youth will be screened using the Scale for Suicide Ideation - Worst Point (SSI-W). We expect that approximately N =100 youth will report suicidal ideation and those youth will also receive the suicide prevention intervention.

Using an intent to treat design, follow-up assessments will be completed at 3, 6, 9 and 12 months post-baseline. Four advocates will provide services so that advocate effects can be examined (Baldwin et al., 2011), and each advocate will provide all opioid and related risk prevention services to the youth on their caseload. Advocates will be crossed by condition to "equate" conditions on advocate characteristics. RA's will be blind to condition at all assessment timepoints.

Project Intervention: Housing + Prevention Services versus Prevention Services alone Housing + Opioid and Related Risk Prevention Services integrates independent housing, Strengths-Based Outreach and Advocacy (SBOA), HIV prevention and MI (Miller \& Rollnick, 2012) and Cognitive Therapy for Suicide Prevention (CTSP). Each component of the intervention is described below.

Strengths-Based Outreach and Advocacy (SBOA). SBOA focuses on identifying and engaging youth from the streets and drop-ins/shelters etc. and assisting these youth to meet their basic needs (i.e., referrals to food pantries), obtain government entitlements (i.e., SSDI/SSI, cash assistance, food stamps), and connect to other needed supports (education, job training). The advocates provide referrals and/or transport youth to appointments as needed. The initial meeting provides an opportunity to gather information. The advocate will review each of six general areas with the youth to gather a history and picture of the current situation: (1) housing needs; (2) health care; (3) food; (4) legal issues, (5) employment and (6) education. The advocate will assist youth assigned to the opioid and related risk prevention services only comparison condition to obtain housing within the community, as is usually provided with SBOA, but unlike the youth in the housing intervention, they are not provided housing by the project. Once this review is complete, an initial intervention plan is developed with specific goals and objectives. Advocates are available 24 hours for crises.

HIV prevention. Every youth will receive the 2-session intervention which uses cognitive-behavioral techniques with a focus on skills building/behaviors (role plays with condom application, cleaning needles, communication/negotiation and problem solving), used in prior projects with homeless youth with success reducing risk behaviors (e.g., Carmona et al., 2014; Slesnick \& Kang, 2008).

Motivational Interviewing (MI). The Project Match manual was adapted for homeless/runaway youth in prior trials in consultation with William R. Miller and Bo Miller (NIAAA grant no. R01AA12173 and NIDA grant R29DA11590). Adaptation of the manual included attention to the unique life situation of homeless youth in understanding motivations and challenges to recovery while homeless. Session 1 begins with a period of open-ended MI, to establish therapeutic rapport and elicit client change talk. In session 2 the advocate continues to focus on enhancing intrinsic motivation for change, developing discrepancy, transitioning as appropriate into the negotiation of a change plan and evoking commitment to the plan.

Cognitive Therapy for Suicide Prevention (CTSP). The Cognitive Therapy Intervention for Suicide Attempters, developed by Aaron Beck, Gregory Brown and Amy Wenzel (Wenzel, Brown, \& Beck, 2009) has shown promising results for both adults (Brown et al., 2005) and youth (Brent et al., 1993; Stanley et al., 2009). This approach is innovative in that suicidal behavior is the primary target for treatment, rather than being secondary to an underlying psychological disorder, which has been the standard in the field (Wenzel et al., 2009). As a short term treatment (10 sessions), the intervention is particularly feasible for youth who have high rates of treatment refusal and drop-out. CTSP is based upon the theoretical assumption that the manner by which people think and interpret their life events determines their emotional and behavioral responses to those events. Hence, maladaptive cognitions associated with suicidal ideation are the primary focus of the treatment.

Housing. Those randomized to receive housing + opioid and related risk prevention services will receive each prevention component above, plus 6-months of housing. The advocate will work with the youth to identify appropriate housing among the available choices. The project will cover damage deposit, application fees (including FABCO report, credit report), and will automatically pay the landlords the rental checks at the beginning of each month. As in the prior Stage 1 and 2 studies, Nationwide Children's Hospital will not sign leases on behalf of the youth, and so the youth will sign the lease.

Conditions
Substance Use
Being tested
Risk Prevention Services + Housing, Risk Prevention Services Only
Medical subject headings
Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Risk Prevention Services + HousingBehavioural

    opioid and related prevention services in addition to 6 months of rental assistance

  • Risk Prevention Services OnlyBehavioural

    opioid and related prevention services for 6 months

Study groups in NCT04135703
Study groupRoleWhat they receive
Risk Prevention Services +HousingExperimentalOpioid and related prevention services including Strengths-Based Outreach and Advocacy (SBOA), MI, HIV risk and suicide prevention (CTSP) as well as rental and utility assistance for 6 months.
Receives: Behavioral: Risk Prevention Services + Housing
Risk Prevention Services OnlyExperimentalOpioid and related prevention services including Strengths-Based Outreach and Advocacy (SBOA), MI, HIV risk and suicide prevention (CTSP).
Receives: Behavioral: Risk Prevention Services Only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frequency (% Days) of Opioid Use in Prior 3 Months

    frequency (% days in prior 90) of opioid use is measured at baseline, 3, 6, 9 and 12 months post-baseline

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2019
  2. Study start23 Jun 2020
  3. Primary completion14 May 2024
  4. Study completion14 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
240 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04135703
Sponsor's protocol ID
2019B0287
Other IDs
UH3DA050174
Acronym
HOME
Status last verified
Jan 2025
First submitted
20 Oct 2019
Last updated
15 Sep 2025
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kuklinski MR, Gibbons BJ, Bowser DM, McCollister KE, Smart R, Dunlap LJ, Shenkar E, Bonar EE, Boomer T, Campbell M, Fiellin LE, Hutton DW, Rao V, Saldana L, Su K, Walton MA, Yilmazer T. Investing in Interventions to Prevent Opioid Use Disorder in Adolescents and Young Adults: Start-up Costs from NIDA's HEAL Prevention Initiative. Prev Sci. 2025 Nov;26(7):1045-1055. doi: 10.1007/s11121-025-01835-6. Epub 2025 Oct 14.

    PubMed 41085955
  • Ahrens K, Blackburn N, Aalsma M, Haggerty K, Kelleher K, Knight DK, Joseph E, Mulford C, Ryle T, Tolou-Shams M. Prevention of Opioid Use and Disorder Among Youth Involved in the Legal System: Innovation and Implementation of Four Studies Funded by the NIDA HEAL Initiative. Prev Sci. 2023 Oct;24(Suppl 1):99-110. doi: 10.1007/s11121-023-01566-6. Epub 2023 Jul 1.

    PubMed 37393415
  • Chavez L, Kelleher K, Bunger A, Brackenoff B, Famelia R, Ford J, Feng X, Mallory A, Martin J, Sheftall A, Walsh L, Yilmazer T, Slesnick N. Housing First Combined with Suicide Treatment Education and Prevention (HOME + STEP): study protocol for a randomized controlled trial. BMC Public Health. 2021 Jun 12;21(1):1128. doi: 10.1186/s12889-021-11133-9.

    PubMed 34118916
  • Slesnick N, Chavez L, Bunger A, Famelia R, Ford J, Feng X, Higgins S, Holowacz E, Jaderlund S, Luthy E, Mallory A, Martin J, Walsh L, Yilmazer T, Kelleher K. Housing, opportunities, motivation and engagement (HOME) for homeless youth at-risk for opioid use disorder: study protocol for a randomized controlled trial. Addict Sci Clin Pract. 2021 May 12;16(1):30. doi: 10.1186/s13722-021-00237-7.

    PubMed 33980315

Questions about this trial

What is this clinical trial studying?

A study testing Risk Prevention Services + Housing and Risk Prevention Services Only in people with Substance Use, run by Ohio State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 15 Sep 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frequency (% Days) of Opioid Use in Prior 3 Months (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04135703, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in